CA1332809C - Compositions pharmaceutiques a liberation prolongee - Google Patents

Compositions pharmaceutiques a liberation prolongee

Info

Publication number
CA1332809C
CA1332809C CA000548872A CA548872A CA1332809C CA 1332809 C CA1332809 C CA 1332809C CA 000548872 A CA000548872 A CA 000548872A CA 548872 A CA548872 A CA 548872A CA 1332809 C CA1332809 C CA 1332809C
Authority
CA
Canada
Prior art keywords
composition according
hydroxypropyl methylcellulose
acetylsalicylic acid
microcrystalline cellulose
weight ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000548872A
Other languages
English (en)
Inventor
Henry C. Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Canada Inc
Original Assignee
Sandoz Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Canada Inc filed Critical Sandoz Canada Inc
Application granted granted Critical
Publication of CA1332809C publication Critical patent/CA1332809C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000548872A 1986-10-09 1987-10-08 Compositions pharmaceutiques a liberation prolongee Expired - Lifetime CA1332809C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8624213 1986-10-09
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CA1332809C true CA1332809C (fr) 1994-11-01

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000548872A Expired - Lifetime CA1332809C (fr) 1986-10-09 1987-10-08 Compositions pharmaceutiques a liberation prolongee

Country Status (24)

Country Link
JP (1) JPS63101334A (fr)
KR (1) KR880004801A (fr)
AU (1) AU7942087A (fr)
BE (1) BE1000732A5 (fr)
CA (1) CA1332809C (fr)
CH (1) CH675831A5 (fr)
DE (1) DE3733540A1 (fr)
DK (1) DK527487A (fr)
ES (1) ES2014518A6 (fr)
FI (1) FI874414A (fr)
FR (1) FR2604902B1 (fr)
GB (2) GB8624213D0 (fr)
GR (1) GR871550B (fr)
HU (1) HU201875B (fr)
IL (1) IL84104A0 (fr)
IT (1) IT1221493B (fr)
LU (1) LU87009A1 (fr)
NL (1) NL8702294A (fr)
NO (1) NO874200L (fr)
NZ (1) NZ222083A (fr)
PH (1) PH24227A (fr)
PT (1) PT85880B (fr)
SE (1) SE8703889L (fr)
ZA (1) ZA877617B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
EA005291B1 (ru) 1999-03-31 2004-12-30 Янссен Фармацевтика Н.В. Применение предварительно желатинированного крахмала в композиции с контролируемым высвобождением
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
CN101039661A (zh) * 2004-09-09 2007-09-19 普西考法玛公司 用于肼苯哒嗪缓释的药物组合物及其作为癌症治疗载体的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
SE8703889L (sv) 1988-04-10
IT1221493B (it) 1990-07-06
GB8624213D0 (en) 1986-11-12
GB2195893B (en) 1991-05-08
DK527487A (da) 1988-04-10
CH675831A5 (fr) 1990-11-15
HUT52958A (en) 1990-09-28
SE8703889D0 (sv) 1987-10-08
GR871550B (en) 1988-02-15
PT85880A (en) 1987-11-01
BE1000732A5 (fr) 1989-03-21
ES2014518A6 (es) 1990-07-16
DE3733540A1 (de) 1988-04-14
DK527487D0 (da) 1987-10-08
KR880004801A (ko) 1988-06-27
JPS63101334A (ja) 1988-05-06
NO874200D0 (no) 1987-10-07
PT85880B (pt) 1990-07-31
NO874200L (no) 1988-04-11
NL8702294A (nl) 1988-05-02
FI874414A (fi) 1988-04-10
ZA877617B (en) 1989-05-30
HU201875B (en) 1991-01-28
IT8748469A0 (it) 1987-10-08
GB2195893A (en) 1988-04-20
GB8723515D0 (en) 1987-11-11
NZ222083A (en) 1991-05-28
FR2604902B1 (fr) 1991-04-26
FI874414A0 (fi) 1987-10-07
FR2604902A1 (fr) 1988-04-15
LU87009A1 (fr) 1988-05-03
IL84104A0 (en) 1988-03-31
AU7942087A (en) 1988-04-14
PH24227A (en) 1990-05-04

Similar Documents

Publication Publication Date Title
EP1058538B2 (fr) Comprime a desintegration rapide
US4842866A (en) Slow release solid preparation
KR101631140B1 (ko) 지속 방출형 경구용 아세트아미노펜/트라마돌 제형
US20210137973A1 (en) Pharmaceutical compositions
US8461210B2 (en) Fast release paracetamol tablets
JPH059413B2 (fr)
AU2002361198B2 (en) 5HT4 partial agonist pharmaceutical compositions
WO2002058676A1 (fr) Formes de dosage pharmaceutique a liberation prolongee possedant des profiles de dissolution a dependance au ph reduite au minimum
AU2002249881A1 (en) Sustained release pharmaceutical dosage forms with minimized PH dependent dissolution profiles
IL135130A (en) A pharmaceutical preparation containing claudronate as an active ingredient and microcrystalline cellulose that has undergone silification as an excipient
TW508242B (en) Pharmaceutical composition comprising paracetamol
JPH07558B2 (ja) モピダモール製剤
CA1332809C (fr) Compositions pharmaceutiques a liberation prolongee
HUE030609T2 (en) New pharmaceutical compositions for the treatment of insomnia
WO1995022974A2 (fr) Comprimes enrobes de paracetamol et de domperidone
EP2983719A1 (fr) Procédé de fabrication de formes pharmaceutiques effervescentes
US4601895A (en) Delayed-action acetylsalicylic acid formulations for oral administration
JP3884056B1 (ja) 口腔内速崩錠の製造方法
JPH10279476A (ja) ロキソプロフェンナトリウム含有錠剤
KR101046789B1 (ko) 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
JPS59193815A (ja) 錠剤の製法
JP4249847B2 (ja) ビタミンkを含有する口腔内崩壊型錠剤
EP0975337A2 (fr) Composition therapeutique
JP2000273038A (ja) 口腔内溶解性錠剤
Nikhate Ram et al. Design, Development and Evaluation of Metoprolol Succinate Extended Release Tablet

Legal Events

Date Code Title Description
MKEX Expiry